It should come as no surprise that the Eastern Bloc powers came up with their own aerial counterparts to the A-10. Though the Republic Fairchild A-10 Thunderbolt II, far better known by its unofficial ...
The Howl R1 is a more portable and affordable little cousin to the thigh-melting R4. It retains the bombproof materials and ...
Now, Garmin are offering their own take on the technology with their zÅ«mo R1 Radar kit, priced at £519.99. The plug-and-play accessory can be fitted with minimal fuss to most motorcycles ...
Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...
Often depicted with a scorpion on her crown, she was known for healing their venomous bites. Muhammad Ismail Khaled, the Secretary General of Egypt's Supreme Council of Antiquities, thinks the ...
Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...
Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...
We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...
Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...
SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.
Eli Lilly has turned to a biotechnology startup for help building its pipeline of cancer drugs, agreeing on Monday to purchase an experimental cancer drug from privately held Scorpion Therapeutics for ...
International packaging and recycling specialist Alpla has made a significant entry into South Africa’s polyethylene terephthalate (PET) recycling market with the launch of a R1.1 billion state ...